MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Antares Pharma Company Profile (NASDAQ:ATRS)

Consensus Ratings for Antares Pharma (NASDAQ:ATRS) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.17 (94.70% upside)

Analysts' Ratings History for Antares Pharma (NASDAQ:ATRS)
Show:
DateFirmActionRatingPrice TargetActions
5/28/2015Jefferies GroupInitiated CoverageBuy$2.15 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Piper JaffrayInitiated CoverageOverweight$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2014JMP SecuritiesInitiated CoverageOutperform$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014OppenheimerLower Price TargetOutperform$6.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2014Ladenburg ThalmannLower Price Target$6.50 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2013Ladenburg ThalmannBoost Price TargetBuy$5.75 -> $6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2013Jefferies GroupBoost Price TargetBuy$5.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2013Ladenburg ThalmannBoost Price TargetBuy$5.00 -> $5.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/2/2013 forward)